Enzo Biochem Receives Notice from NYSE Regarding Listing ComplianceFarmingdale, NY – Enzo Biochem, Inc. (NYSE: ENZ) recently disclosed that it received a notice from the New York Stock Exchange (NYSE) indicating non-compliance with certain listing st

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Enzo Biochem’s 8K filing here.

Enzo Biochem Company Profile

(Get Free Report)

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.

See Also